nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—Sulfonylurea Compounds—Chlorpropamide—type 2 diabetes mellitus	0.0627	0.21	CiPCiCtD
Tolbutamide—Sulfonylurea Compounds—Glipizide—type 2 diabetes mellitus	0.0627	0.21	CiPCiCtD
Tolbutamide—Sulfonylurea Compounds—Glimepiride—type 2 diabetes mellitus	0.0627	0.21	CiPCiCtD
Tolbutamide—Sulfonylurea Compounds—Tolazamide—type 2 diabetes mellitus	0.0627	0.21	CiPCiCtD
Tolbutamide—ABCC8—type 2 diabetes mellitus	0.0548	0.587	CbGaD
Tolbutamide—Tolazamide—type 2 diabetes mellitus	0.0489	0.21	CrCtD
Tolbutamide—Glimepiride—type 2 diabetes mellitus	0.0489	0.21	CrCtD
Tolbutamide—Sulfonylurea Compounds—Glyburide—type 2 diabetes mellitus	0.0475	0.159	CiPCiCtD
Tolbutamide—Gliclazide—type 2 diabetes mellitus	0.0463	0.199	CrCtD
Tolbutamide—Glipizide—type 2 diabetes mellitus	0.0463	0.199	CrCtD
Tolbutamide—Chlorpropamide—type 2 diabetes mellitus	0.0424	0.182	CrCtD
Tolbutamide—KCNJ11—type 2 diabetes mellitus	0.0386	0.413	CbGaD
Tolbutamide—KCNJ1—Tolazamide—type 2 diabetes mellitus	0.016	0.0988	CbGbCtD
Tolbutamide—KCNJ1—Glimepiride—type 2 diabetes mellitus	0.0142	0.0881	CbGbCtD
Tolbutamide—ABCC8—Tolazamide—type 2 diabetes mellitus	0.00868	0.0537	CbGbCtD
Tolbutamide—ABCC8—Glimepiride—type 2 diabetes mellitus	0.00773	0.0479	CbGbCtD
Tolbutamide—KCNJ11—Tolazamide—type 2 diabetes mellitus	0.0075	0.0464	CbGbCtD
Tolbutamide—ABCC8—Glipizide—type 2 diabetes mellitus	0.00707	0.0438	CbGbCtD
Tolbutamide—Probenecid—Chlorpropamide—type 2 diabetes mellitus	0.00701	0.0457	CrCrCtD
Tolbutamide—KCNJ11—Glimepiride—type 2 diabetes mellitus	0.00668	0.0414	CbGbCtD
Tolbutamide—ABCC8—Gliclazide—type 2 diabetes mellitus	0.00657	0.0407	CbGbCtD
Tolbutamide—ABCC8—Repaglinide—type 2 diabetes mellitus	0.00618	0.0383	CbGbCtD
Tolbutamide—KCNJ11—Glipizide—type 2 diabetes mellitus	0.00611	0.0378	CbGbCtD
Tolbutamide—Glimepiride—Glipizide—type 2 diabetes mellitus	0.00586	0.0382	CrCrCtD
Tolbutamide—Glimepiride—Gliclazide—type 2 diabetes mellitus	0.00586	0.0382	CrCrCtD
Tolbutamide—Tolazamide—Glipizide—type 2 diabetes mellitus	0.00586	0.0382	CrCrCtD
Tolbutamide—Tolazamide—Gliclazide—type 2 diabetes mellitus	0.00586	0.0382	CrCrCtD
Tolbutamide—KCNJ11—Gliclazide—type 2 diabetes mellitus	0.00568	0.0352	CbGbCtD
Tolbutamide—ABCC8—Chlorpropamide—type 2 diabetes mellitus	0.00559	0.0346	CbGbCtD
Tolbutamide—Glipizide—Tolazamide—type 2 diabetes mellitus	0.00555	0.0362	CrCrCtD
Tolbutamide—Glipizide—Glimepiride—type 2 diabetes mellitus	0.00555	0.0362	CrCrCtD
Tolbutamide—Gliclazide—Tolazamide—type 2 diabetes mellitus	0.00555	0.0362	CrCrCtD
Tolbutamide—Gliclazide—Glimepiride—type 2 diabetes mellitus	0.00555	0.0362	CrCrCtD
Tolbutamide—Tolazamide—Chlorpropamide—type 2 diabetes mellitus	0.00536	0.0349	CrCrCtD
Tolbutamide—Glimepiride—Chlorpropamide—type 2 diabetes mellitus	0.00536	0.0349	CrCrCtD
Tolbutamide—KCNJ11—Repaglinide—type 2 diabetes mellitus	0.00534	0.0331	CbGbCtD
Tolbutamide—Glipizide—Gliclazide—type 2 diabetes mellitus	0.00527	0.0343	CrCrCtD
Tolbutamide—Gliclazide—Glipizide—type 2 diabetes mellitus	0.00527	0.0343	CrCrCtD
Tolbutamide—KCNJ1—Glyburide—type 2 diabetes mellitus	0.00527	0.0326	CbGbCtD
Tolbutamide—Glisoxepide—Glimepiride—type 2 diabetes mellitus	0.00506	0.0329	CrCrCtD
Tolbutamide—Glisoxepide—Tolazamide—type 2 diabetes mellitus	0.00506	0.0329	CrCrCtD
Tolbutamide—KCNJ11—Chlorpropamide—type 2 diabetes mellitus	0.00483	0.0299	CbGbCtD
Tolbutamide—Gliclazide—Chlorpropamide—type 2 diabetes mellitus	0.00482	0.0314	CrCrCtD
Tolbutamide—Glipizide—Chlorpropamide—type 2 diabetes mellitus	0.00482	0.0314	CrCrCtD
Tolbutamide—Glisoxepide—Gliclazide—type 2 diabetes mellitus	0.00479	0.0312	CrCrCtD
Tolbutamide—Glisoxepide—Glipizide—type 2 diabetes mellitus	0.00479	0.0312	CrCrCtD
Tolbutamide—Chlorpropamide—Glimepiride—type 2 diabetes mellitus	0.00465	0.0303	CrCrCtD
Tolbutamide—Chlorpropamide—Tolazamide—type 2 diabetes mellitus	0.00465	0.0303	CrCrCtD
Tolbutamide—Chlorpropamide—Gliclazide—type 2 diabetes mellitus	0.00441	0.0287	CrCrCtD
Tolbutamide—Chlorpropamide—Glipizide—type 2 diabetes mellitus	0.00441	0.0287	CrCrCtD
Tolbutamide—Glisoxepide—Chlorpropamide—type 2 diabetes mellitus	0.00438	0.0286	CrCrCtD
Tolbutamide—ABCC8—Nateglinide—type 2 diabetes mellitus	0.00424	0.0262	CbGbCtD
Tolbutamide—Tolazamide—Glyburide—type 2 diabetes mellitus	0.00406	0.0265	CrCrCtD
Tolbutamide—Glimepiride—Glyburide—type 2 diabetes mellitus	0.00406	0.0265	CrCrCtD
Tolbutamide—KCNJ11—Nateglinide—type 2 diabetes mellitus	0.00366	0.0227	CbGbCtD
Tolbutamide—Gliclazide—Glyburide—type 2 diabetes mellitus	0.00365	0.0238	CrCrCtD
Tolbutamide—Glipizide—Glyburide—type 2 diabetes mellitus	0.00365	0.0238	CrCrCtD
Tolbutamide—Glisoxepide—Glyburide—type 2 diabetes mellitus	0.00332	0.0216	CrCrCtD
Tolbutamide—Chlorpropamide—Glyburide—type 2 diabetes mellitus	0.00305	0.0199	CrCrCtD
Tolbutamide—ABCC8—Glyburide—type 2 diabetes mellitus	0.00286	0.0177	CbGbCtD
Tolbutamide—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0026	0.0161	CbGbCtD
Tolbutamide—KCNJ11—Glyburide—type 2 diabetes mellitus	0.00247	0.0153	CbGbCtD
Tolbutamide—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.00224	0.0139	CbGbCtD
Tolbutamide—Sulfacetamide—Tolazamide—type 2 diabetes mellitus	0.0021	0.0137	CrCrCtD
Tolbutamide—SLC15A2—Ramipril—type 2 diabetes mellitus	0.00207	0.0128	CbGbCtD
Tolbutamide—Sulfacetamide—Gliclazide—type 2 diabetes mellitus	0.00199	0.013	CrCrCtD
Tolbutamide—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.00197	0.0122	CbGbCtD
Tolbutamide—SLCO2B1—Glyburide—type 2 diabetes mellitus	0.0019	0.0118	CbGbCtD
Tolbutamide—Sulfacetamide—Chlorpropamide—type 2 diabetes mellitus	0.00182	0.0119	CrCrCtD
Tolbutamide—SLC15A1—Ramipril—type 2 diabetes mellitus	0.00178	0.011	CbGbCtD
Tolbutamide—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0017	0.0105	CbGbCtD
Tolbutamide—SLC15A2—Glyburide—type 2 diabetes mellitus	0.00133	0.00825	CbGbCtD
Tolbutamide—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.00124	0.00765	CbGbCtD
Tolbutamide—SLC15A1—Glyburide—type 2 diabetes mellitus	0.00115	0.0071	CbGbCtD
Tolbutamide—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00112	0.00696	CbGbCtD
Tolbutamide—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.00104	0.00645	CbGbCtD
Tolbutamide—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.000936	0.0058	CbGbCtD
Tolbutamide—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.000899	0.00557	CbGbCtD
Tolbutamide—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.000813	0.00503	CbGbCtD
Tolbutamide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.000802	0.00497	CbGbCtD
Tolbutamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.000784	0.00486	CbGbCtD
Tolbutamide—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00075	0.00464	CbGbCtD
Tolbutamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.000717	0.00444	CbGbCtD
Tolbutamide—ABCC8—penis—type 2 diabetes mellitus	0.000691	0.189	CbGeAlD
Tolbutamide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.000682	0.00422	CbGbCtD
Tolbutamide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.000682	0.00422	CbGbCtD
Tolbutamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.000667	0.00413	CbGbCtD
Tolbutamide—SLC22A6—Glyburide—type 2 diabetes mellitus	0.000632	0.00391	CbGbCtD
Tolbutamide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.000629	0.0039	CbGbCtD
Tolbutamide—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.000591	0.00366	CbGbCtD
Tolbutamide—SLC22A6—Losartan—type 2 diabetes mellitus	0.000578	0.00358	CbGbCtD
Tolbutamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.000567	0.00351	CbGbCtD
Tolbutamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.000567	0.00351	CbGbCtD
Tolbutamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.000523	0.00324	CbGbCtD
Tolbutamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.000462	0.00286	CbGbCtD
Tolbutamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00043	0.00266	CbGbCtD
Tolbutamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.000412	0.00255	CbGbCtD
Tolbutamide—CYP2C8—Losartan—type 2 diabetes mellitus	0.000381	0.00236	CbGbCtD
Tolbutamide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.000349	0.00216	CbGbCtD
Tolbutamide—CYP2C19—Losartan—type 2 diabetes mellitus	0.000319	0.00198	CbGbCtD
Tolbutamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00029	0.0018	CbGbCtD
Tolbutamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.000266	0.00164	CbGbCtD
Tolbutamide—KCNJ1—nephron tubule—type 2 diabetes mellitus	0.000221	0.0605	CbGeAlD
Tolbutamide—KCNJ1—kidney—type 2 diabetes mellitus	0.000195	0.0532	CbGeAlD
Tolbutamide—KCNJ1—cortex of kidney—type 2 diabetes mellitus	0.000189	0.0518	CbGeAlD
Tolbutamide—KCNJ11—islet of Langerhans—type 2 diabetes mellitus	0.000167	0.0456	CbGeAlD
Tolbutamide—ABCC8—islet of Langerhans—type 2 diabetes mellitus	0.000154	0.042	CbGeAlD
Tolbutamide—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000142	0.0388	CbGeAlD
Tolbutamide—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000122	0.0332	CbGeAlD
Tolbutamide—KCNJ11—cardiovascular system—type 2 diabetes mellitus	0.000121	0.033	CbGeAlD
Tolbutamide—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000118	0.0323	CbGeAlD
Tolbutamide—KCNJ11—pancreas—type 2 diabetes mellitus	0.000117	0.032	CbGeAlD
Tolbutamide—Tolazamide—ABCC8—type 2 diabetes mellitus	0.000113	0.105	CrCbGaD
Tolbutamide—ABCC8—cardiovascular system—type 2 diabetes mellitus	0.000111	0.0304	CbGeAlD
Tolbutamide—ABCC8—kidney—type 2 diabetes mellitus	0.000109	0.0297	CbGeAlD
Tolbutamide—ABCC8—pancreas—type 2 diabetes mellitus	0.000108	0.0295	CbGeAlD
Tolbutamide—Hypoglycaemia—Tolazamide—type 2 diabetes mellitus	0.000105	0.00261	CcSEcCtD
Tolbutamide—Hypoglycaemia—Chlorpropamide—type 2 diabetes mellitus	0.000105	0.00261	CcSEcCtD
Tolbutamide—Heartburn—Glyburide—type 2 diabetes mellitus	0.000105	0.0026	CcSEcCtD
Tolbutamide—Hypoglycaemia—Linagliptin—type 2 diabetes mellitus	0.000104	0.00258	CcSEcCtD
Tolbutamide—SLC15A1—kidney—type 2 diabetes mellitus	0.000104	0.0284	CbGeAlD
Tolbutamide—Hyponatraemia—Chlorpropamide—type 2 diabetes mellitus	0.000103	0.00255	CcSEcCtD
Tolbutamide—Hyponatraemia—Tolazamide—type 2 diabetes mellitus	0.000103	0.00255	CcSEcCtD
Tolbutamide—Glisoxepide—ABCC8—type 2 diabetes mellitus	0.000103	0.0951	CrCbGaD
Tolbutamide—Glimepiride—ABCC8—type 2 diabetes mellitus	0.000101	0.0937	CrCbGaD
Tolbutamide—Hypoglycaemia—Nateglinide—type 2 diabetes mellitus	9.76e-05	0.00242	CcSEcCtD
Tolbutamide—Digestion impaired—Gliclazide—type 2 diabetes mellitus	9.72e-05	0.0024	CcSEcCtD
Tolbutamide—Heartburn—Gliclazide—type 2 diabetes mellitus	9.44e-05	0.00233	CcSEcCtD
Tolbutamide—CYP2C18—liver—type 2 diabetes mellitus	9.32e-05	0.0255	CbGeAlD
Tolbutamide—Haemolytic anaemia—Repaglinide—type 2 diabetes mellitus	9.13e-05	0.00226	CcSEcCtD
Tolbutamide—Abdominal distension—Tolazamide—type 2 diabetes mellitus	8.95e-05	0.00221	CcSEcCtD
Tolbutamide—Aplastic anaemia—Glipizide—type 2 diabetes mellitus	8.82e-05	0.00218	CcSEcCtD
Tolbutamide—Glipizide—ABCC8—type 2 diabetes mellitus	8.77e-05	0.0813	CrCbGaD
Tolbutamide—SLCO2B1—kidney—type 2 diabetes mellitus	8.51e-05	0.0232	CbGeAlD
Tolbutamide—Hypoglycaemia—Repaglinide—type 2 diabetes mellitus	8.45e-05	0.00209	CcSEcCtD
Tolbutamide—Pancytopenia—Tolazamide—type 2 diabetes mellitus	8.44e-05	0.00209	CcSEcCtD
Tolbutamide—Pancytopenia—Chlorpropamide—type 2 diabetes mellitus	8.44e-05	0.00209	CcSEcCtD
Tolbutamide—Aplastic anaemia—Glimepiride—type 2 diabetes mellitus	8.23e-05	0.00204	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Glyburide—type 2 diabetes mellitus	8.23e-05	0.00204	CcSEcCtD
Tolbutamide—Gliclazide—ABCC8—type 2 diabetes mellitus	8.15e-05	0.0755	CrCbGaD
Tolbutamide—Photosensitivity reaction—Chlorpropamide—type 2 diabetes mellitus	8.11e-05	0.00201	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Tolazamide—type 2 diabetes mellitus	8.11e-05	0.00201	CcSEcCtD
Tolbutamide—Tolazamide—KCNJ11—type 2 diabetes mellitus	7.99e-05	0.0741	CrCbGaD
Tolbutamide—Hypoglycaemia—Rosiglitazone—type 2 diabetes mellitus	7.99e-05	0.00198	CcSEcCtD
Tolbutamide—Heartburn—Metformin—type 2 diabetes mellitus	7.9e-05	0.00195	CcSEcCtD
Tolbutamide—SLC15A2—retina—type 2 diabetes mellitus	7.85e-05	0.0214	CbGeAlD
Tolbutamide—SLCO1A2—kidney—type 2 diabetes mellitus	7.83e-05	0.0214	CbGeAlD
Tolbutamide—SLCO2B1—adipose tissue—type 2 diabetes mellitus	7.67e-05	0.021	CbGeAlD
Tolbutamide—Haemolytic anaemia—Glipizide—type 2 diabetes mellitus	7.56e-05	0.00187	CcSEcCtD
Tolbutamide—Heartburn—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.00184	CcSEcCtD
Tolbutamide—Agranulocytosis—Chlorpropamide—type 2 diabetes mellitus	7.4e-05	0.00183	CcSEcCtD
Tolbutamide—Agranulocytosis—Tolazamide—type 2 diabetes mellitus	7.4e-05	0.00183	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Gliclazide—type 2 diabetes mellitus	7.39e-05	0.00183	CcSEcCtD
Tolbutamide—SLC15A2—nephron tubule—type 2 diabetes mellitus	7.39e-05	0.0202	CbGeAlD
Tolbutamide—Glisoxepide—KCNJ11—type 2 diabetes mellitus	7.23e-05	0.067	CrCbGaD
Tolbutamide—Glimepiride—KCNJ11—type 2 diabetes mellitus	7.12e-05	0.066	CrCbGaD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Ramipril—type 2 diabetes mellitus	7.12e-05	0.00176	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Glimepiride—type 2 diabetes mellitus	7.05e-05	0.00174	CcSEcCtD
Tolbutamide—Hypoglycaemia—Glipizide—type 2 diabetes mellitus	6.99e-05	0.00173	CcSEcCtD
Tolbutamide—Hyponatraemia—Glipizide—type 2 diabetes mellitus	6.85e-05	0.00169	CcSEcCtD
Tolbutamide—Aplastic anaemia—Glyburide—type 2 diabetes mellitus	6.79e-05	0.00168	CcSEcCtD
Tolbutamide—Hypoglycaemia—Pioglitazone—type 2 diabetes mellitus	6.7e-05	0.00166	CcSEcCtD
Tolbutamide—SLC15A1—liver—type 2 diabetes mellitus	6.57e-05	0.0179	CbGeAlD
Tolbutamide—Hypoglycaemia—Glimepiride—type 2 diabetes mellitus	6.52e-05	0.00161	CcSEcCtD
Tolbutamide—Hypoglycaemia—Sitagliptin—type 2 diabetes mellitus	6.5e-05	0.00161	CcSEcCtD
Tolbutamide—SLC15A2—kidney—type 2 diabetes mellitus	6.5e-05	0.0178	CbGeAlD
Tolbutamide—Hyponatraemia—Glimepiride—type 2 diabetes mellitus	6.39e-05	0.00158	CcSEcCtD
Tolbutamide—Chlorpropamide—ABCC8—type 2 diabetes mellitus	6.34e-05	0.0587	CrCbGaD
Tolbutamide—SLC15A2—cortex of kidney—type 2 diabetes mellitus	6.33e-05	0.0173	CbGeAlD
Tolbutamide—Erythema—Tolazamide—type 2 diabetes mellitus	6.19e-05	0.00153	CcSEcCtD
Tolbutamide—Digestion impaired—Ramipril—type 2 diabetes mellitus	6.19e-05	0.00153	CcSEcCtD
Tolbutamide—Glipizide—KCNJ11—type 2 diabetes mellitus	6.18e-05	0.0572	CrCbGaD
Tolbutamide—Erythema—Acarbose—type 2 diabetes mellitus	5.95e-05	0.00147	CcSEcCtD
Tolbutamide—Hypoglycaemia—Bromocriptine—type 2 diabetes mellitus	5.89e-05	0.00146	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.00144	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Glyburide—type 2 diabetes mellitus	5.82e-05	0.00144	CcSEcCtD
Tolbutamide—Gliclazide—KCNJ11—type 2 diabetes mellitus	5.74e-05	0.0532	CrCbGaD
Tolbutamide—Pancytopenia—Glipizide—type 2 diabetes mellitus	5.6e-05	0.00139	CcSEcCtD
Tolbutamide—Leukopenia—Chlorpropamide—type 2 diabetes mellitus	5.54e-05	0.00137	CcSEcCtD
Tolbutamide—Leukopenia—Tolazamide—type 2 diabetes mellitus	5.54e-05	0.00137	CcSEcCtD
Tolbutamide—Abdominal distension—Glimepiride—type 2 diabetes mellitus	5.54e-05	0.00137	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Losartan—type 2 diabetes mellitus	5.49e-05	0.00136	CcSEcCtD
Tolbutamide—CYP2C8—kidney—type 2 diabetes mellitus	5.47e-05	0.0149	CbGeAlD
Tolbutamide—Photosensitivity reaction—Glipizide—type 2 diabetes mellitus	5.38e-05	0.00133	CcSEcCtD
Tolbutamide—Hypoglycaemia—Glyburide—type 2 diabetes mellitus	5.38e-05	0.00133	CcSEcCtD
Tolbutamide—SLCO2B1—liver—type 2 diabetes mellitus	5.38e-05	0.0147	CbGeAlD
Tolbutamide—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	5.33e-05	0.00132	CcSEcCtD
Tolbutamide—Hyponatraemia—Glyburide—type 2 diabetes mellitus	5.27e-05	0.0013	CcSEcCtD
Tolbutamide—Pancytopenia—Glimepiride—type 2 diabetes mellitus	5.23e-05	0.00129	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Gliclazide—type 2 diabetes mellitus	5.22e-05	0.00129	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Glimepiride—type 2 diabetes mellitus	5.02e-05	0.00124	CcSEcCtD
Tolbutamide—Erythema—Repaglinide—type 2 diabetes mellitus	4.97e-05	0.00123	CcSEcCtD
Tolbutamide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	4.97e-05	0.0136	CbGeAlD
Tolbutamide—Thrombocytopenia—Chlorpropamide—type 2 diabetes mellitus	4.95e-05	0.00122	CcSEcCtD
Tolbutamide—Thrombocytopenia—Tolazamide—type 2 diabetes mellitus	4.95e-05	0.00122	CcSEcCtD
Tolbutamide—SLCO1A2—liver—type 2 diabetes mellitus	4.95e-05	0.0135	CbGeAlD
Tolbutamide—Agranulocytosis—Glipizide—type 2 diabetes mellitus	4.91e-05	0.00121	CcSEcCtD
Tolbutamide—Hypoglycaemia—Gliclazide—type 2 diabetes mellitus	4.83e-05	0.0012	CcSEcCtD
Tolbutamide—Aplastic anaemia—Irbesartan—type 2 diabetes mellitus	4.81e-05	0.00119	CcSEcCtD
Tolbutamide—Thrombocytopenia—Acarbose—type 2 diabetes mellitus	4.75e-05	0.00118	CcSEcCtD
Tolbutamide—Hyponatraemia—Gliclazide—type 2 diabetes mellitus	4.73e-05	0.00117	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Ramipril—type 2 diabetes mellitus	4.71e-05	0.00117	CcSEcCtD
Tolbutamide—Agranulocytosis—Glimepiride—type 2 diabetes mellitus	4.58e-05	0.00113	CcSEcCtD
Tolbutamide—Abdominal distension—Glyburide—type 2 diabetes mellitus	4.57e-05	0.00113	CcSEcCtD
Tolbutamide—Aplastic anaemia—Losartan—type 2 diabetes mellitus	4.53e-05	0.00112	CcSEcCtD
Tolbutamide—Chlorpropamide—KCNJ11—type 2 diabetes mellitus	4.47e-05	0.0414	CrCbGaD
Tolbutamide—Gliclazide—VEGFA—type 2 diabetes mellitus	4.45e-05	0.0413	CrCbGaD
Tolbutamide—Dyspepsia—Tolazamide—type 2 diabetes mellitus	4.45e-05	0.0011	CcSEcCtD
Tolbutamide—Dyspepsia—Chlorpropamide—type 2 diabetes mellitus	4.45e-05	0.0011	CcSEcCtD
Tolbutamide—Leukopenia—Repaglinide—type 2 diabetes mellitus	4.45e-05	0.0011	CcSEcCtD
Tolbutamide—Hypoglycaemia—Orlistat—type 2 diabetes mellitus	4.39e-05	0.00109	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	4.36e-05	0.00108	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	4.36e-05	0.00108	CcSEcCtD
Tolbutamide—Hyponatraemia—Valsartan—type 2 diabetes mellitus	4.35e-05	0.00108	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	4.32e-05	0.00107	CcSEcCtD
Tolbutamide—Pancytopenia—Glyburide—type 2 diabetes mellitus	4.31e-05	0.00107	CcSEcCtD
Tolbutamide—Dyspepsia—Acarbose—type 2 diabetes mellitus	4.27e-05	0.00106	CcSEcCtD
Tolbutamide—Leukopenia—Rosiglitazone—type 2 diabetes mellitus	4.2e-05	0.00104	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	4.19e-05	0.00104	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Glyburide—type 2 diabetes mellitus	4.14e-05	0.00102	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Irbesartan—type 2 diabetes mellitus	4.12e-05	0.00102	CcSEcCtD
Tolbutamide—Dyspepsia—Nateglinide—type 2 diabetes mellitus	4.12e-05	0.00102	CcSEcCtD
Tolbutamide—Erythema—Glipizide—type 2 diabetes mellitus	4.11e-05	0.00102	CcSEcCtD
Tolbutamide—Abdominal distension—Gliclazide—type 2 diabetes mellitus	4.1e-05	0.00101	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	4.04e-05	0.001	CcSEcCtD
Tolbutamide—Hypoglycaemia—Metformin—type 2 diabetes mellitus	4.04e-05	0.001	CcSEcCtD
Tolbutamide—Urticaria—Chlorpropamide—type 2 diabetes mellitus	4.02e-05	0.000993	CcSEcCtD
Tolbutamide—Urticaria—Tolazamide—type 2 diabetes mellitus	4.02e-05	0.000993	CcSEcCtD
Tolbutamide—Urticaria—Linagliptin—type 2 diabetes mellitus	3.97e-05	0.000983	CcSEcCtD
Tolbutamide—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	3.97e-05	0.000982	CcSEcCtD
Tolbutamide—CYP2C19—liver—type 2 diabetes mellitus	3.96e-05	0.0108	CbGeAlD
Tolbutamide—Rash—Miglitol—type 2 diabetes mellitus	3.9e-05	0.000964	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Losartan—type 2 diabetes mellitus	3.88e-05	0.00096	CcSEcCtD
Tolbutamide—Pancytopenia—Gliclazide—type 2 diabetes mellitus	3.87e-05	0.000957	CcSEcCtD
Tolbutamide—Urticaria—Acarbose—type 2 diabetes mellitus	3.86e-05	0.000954	CcSEcCtD
Tolbutamide—Erythema—Glimepiride—type 2 diabetes mellitus	3.83e-05	0.000949	CcSEcCtD
Tolbutamide—Agranulocytosis—Glyburide—type 2 diabetes mellitus	3.78e-05	0.000934	CcSEcCtD
Tolbutamide—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	3.75e-05	0.000928	CcSEcCtD
Tolbutamide—Hyponatraemia—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000925	CcSEcCtD
Tolbutamide—Abdominal distension—Orlistat—type 2 diabetes mellitus	3.72e-05	0.000921	CcSEcCtD
Tolbutamide—Urticaria—Nateglinide—type 2 diabetes mellitus	3.72e-05	0.00092	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Gliclazide—type 2 diabetes mellitus	3.72e-05	0.00092	CcSEcCtD
Tolbutamide—Leukopenia—Glipizide—type 2 diabetes mellitus	3.68e-05	0.00091	CcSEcCtD
Tolbutamide—Nausea—Miglitol—type 2 diabetes mellitus	3.67e-05	0.000908	CcSEcCtD
Tolbutamide—Hypoglycaemia—Losartan—type 2 diabetes mellitus	3.59e-05	0.000888	CcSEcCtD
Tolbutamide—Pruritus—Tolazamide—type 2 diabetes mellitus	3.58e-05	0.000885	CcSEcCtD
Tolbutamide—Pruritus—Chlorpropamide—type 2 diabetes mellitus	3.58e-05	0.000885	CcSEcCtD
Tolbutamide—Dyspepsia—Repaglinide—type 2 diabetes mellitus	3.57e-05	0.000883	CcSEcCtD
Tolbutamide—Hyponatraemia—Losartan—type 2 diabetes mellitus	3.52e-05	0.00087	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	3.5e-05	0.000866	CcSEcCtD
Tolbutamide—CYP2C8—liver—type 2 diabetes mellitus	3.46e-05	0.00945	CbGeAlD
Tolbutamide—Abdominal distension—Metformin—type 2 diabetes mellitus	3.43e-05	0.000849	CcSEcCtD
Tolbutamide—Leukopenia—Glimepiride—type 2 diabetes mellitus	3.43e-05	0.000849	CcSEcCtD
Tolbutamide—Glipizide—PPARG—type 2 diabetes mellitus	3.42e-05	0.0317	CrCbGaD
Tolbutamide—Photosensitivity reaction—Valsartan—type 2 diabetes mellitus	3.42e-05	0.000845	CcSEcCtD
Tolbutamide—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	3.39e-05	0.000839	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000823	CcSEcCtD
Tolbutamide—Pruritus—Nateglinide—type 2 diabetes mellitus	3.31e-05	0.00082	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	3.31e-05	0.000818	CcSEcCtD
Tolbutamide—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	3.28e-05	0.000812	CcSEcCtD
Tolbutamide—Abdominal distension—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.000801	CcSEcCtD
Tolbutamide—Urticaria—Repaglinide—type 2 diabetes mellitus	3.22e-05	0.000797	CcSEcCtD
Tolbutamide—Rash—Chlorpropamide—type 2 diabetes mellitus	3.19e-05	0.000788	CcSEcCtD
Tolbutamide—Rash—Tolazamide—type 2 diabetes mellitus	3.19e-05	0.000788	CcSEcCtD
Tolbutamide—Headache—Tolazamide—type 2 diabetes mellitus	3.17e-05	0.000783	CcSEcCtD
Tolbutamide—Headache—Chlorpropamide—type 2 diabetes mellitus	3.17e-05	0.000783	CcSEcCtD
Tolbutamide—Erythema—Glyburide—type 2 diabetes mellitus	3.16e-05	0.000782	CcSEcCtD
Tolbutamide—Rash—Linagliptin—type 2 diabetes mellitus	3.15e-05	0.00078	CcSEcCtD
Tolbutamide—Headache—Linagliptin—type 2 diabetes mellitus	3.13e-05	0.000775	CcSEcCtD
Tolbutamide—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000762	CcSEcCtD
Tolbutamide—CYP2C9—liver—type 2 diabetes mellitus	3.07e-05	0.00839	CbGeAlD
Tolbutamide—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	3.06e-05	0.000758	CcSEcCtD
Tolbutamide—Rash—Acarbose—type 2 diabetes mellitus	3.06e-05	0.000758	CcSEcCtD
Tolbutamide—Urticaria—Rosiglitazone—type 2 diabetes mellitus	3.04e-05	0.000753	CcSEcCtD
Tolbutamide—Hyponatraemia—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000746	CcSEcCtD
Tolbutamide—Nausea—Chlorpropamide—type 2 diabetes mellitus	3e-05	0.000743	CcSEcCtD
Tolbutamide—Nausea—Tolazamide—type 2 diabetes mellitus	3e-05	0.000743	CcSEcCtD
Tolbutamide—Rash—Nateglinide—type 2 diabetes mellitus	2.95e-05	0.00073	CcSEcCtD
Tolbutamide—Dyspepsia—Glipizide—type 2 diabetes mellitus	2.95e-05	0.00073	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Irbesartan—type 2 diabetes mellitus	2.94e-05	0.000727	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	2.89e-05	0.000716	CcSEcCtD
Tolbutamide—Nausea—Acarbose—type 2 diabetes mellitus	2.88e-05	0.000714	CcSEcCtD
Tolbutamide—Pruritus—Repaglinide—type 2 diabetes mellitus	2.87e-05	0.000709	CcSEcCtD
Tolbutamide—Erythema—Gliclazide—type 2 diabetes mellitus	2.84e-05	0.000702	CcSEcCtD
Tolbutamide—Leukopenia—Glyburide—type 2 diabetes mellitus	2.83e-05	0.0007	CcSEcCtD
Tolbutamide—Nausea—Nateglinide—type 2 diabetes mellitus	2.78e-05	0.000688	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	2.77e-05	0.000686	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	2.76e-05	0.000684	CcSEcCtD
Tolbutamide—Dyspepsia—Glimepiride—type 2 diabetes mellitus	2.75e-05	0.000681	CcSEcCtD
Tolbutamide—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	2.75e-05	0.000679	CcSEcCtD
Tolbutamide—Pruritus—Rosiglitazone—type 2 diabetes mellitus	2.71e-05	0.00067	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	2.7e-05	0.000668	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	2.69e-05	0.000666	CcSEcCtD
Tolbutamide—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	2.68e-05	0.000662	CcSEcCtD
Tolbutamide—Urticaria—Glipizide—type 2 diabetes mellitus	2.66e-05	0.000659	CcSEcCtD
Tolbutamide—Rash—Repaglinide—type 2 diabetes mellitus	2.56e-05	0.000632	CcSEcCtD
Tolbutamide—Urticaria—Pioglitazone—type 2 diabetes mellitus	2.55e-05	0.000631	CcSEcCtD
Tolbutamide—Leukopenia—Gliclazide—type 2 diabetes mellitus	2.54e-05	0.000629	CcSEcCtD
Tolbutamide—Headache—Repaglinide—type 2 diabetes mellitus	2.54e-05	0.000628	CcSEcCtD
Tolbutamide—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	2.53e-05	0.000625	CcSEcCtD
Tolbutamide—Agranulocytosis—Losartan—type 2 diabetes mellitus	2.52e-05	0.000623	CcSEcCtD
Tolbutamide—Urticaria—Glimepiride—type 2 diabetes mellitus	2.49e-05	0.000615	CcSEcCtD
Tolbutamide—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	2.48e-05	0.000615	CcSEcCtD
Tolbutamide—Urticaria—Sitagliptin—type 2 diabetes mellitus	2.48e-05	0.000613	CcSEcCtD
Tolbutamide—Pancytopenia—Ramipril—type 2 diabetes mellitus	2.47e-05	0.00061	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	2.44e-05	0.000603	CcSEcCtD
Tolbutamide—Rash—Rosiglitazone—type 2 diabetes mellitus	2.42e-05	0.000598	CcSEcCtD
Tolbutamide—Nausea—Repaglinide—type 2 diabetes mellitus	2.41e-05	0.000596	CcSEcCtD
Tolbutamide—Headache—Rosiglitazone—type 2 diabetes mellitus	2.4e-05	0.000594	CcSEcCtD
Tolbutamide—Erythema—Metformin—type 2 diabetes mellitus	2.38e-05	0.000588	CcSEcCtD
Tolbutamide—Pruritus—Glipizide—type 2 diabetes mellitus	2.37e-05	0.000587	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000586	CcSEcCtD
Tolbutamide—Nausea—Rosiglitazone—type 2 diabetes mellitus	2.28e-05	0.000563	CcSEcCtD
Tolbutamide—Dyspepsia—Glyburide—type 2 diabetes mellitus	2.27e-05	0.000562	CcSEcCtD
Tolbutamide—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	2.27e-05	0.000561	CcSEcCtD
Tolbutamide—Urticaria—Bromocriptine—type 2 diabetes mellitus	2.24e-05	0.000555	CcSEcCtD
Tolbutamide—Erythema—Irbesartan—type 2 diabetes mellitus	2.24e-05	0.000555	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	2.23e-05	0.000551	CcSEcCtD
Tolbutamide—Pruritus—Glimepiride—type 2 diabetes mellitus	2.21e-05	0.000548	CcSEcCtD
Tolbutamide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	2.16e-05	0.000534	CcSEcCtD
Tolbutamide—Rash—Glipizide—type 2 diabetes mellitus	2.11e-05	0.000523	CcSEcCtD
Tolbutamide—Erythema—Losartan—type 2 diabetes mellitus	2.11e-05	0.000522	CcSEcCtD
Tolbutamide—Headache—Glipizide—type 2 diabetes mellitus	2.1e-05	0.00052	CcSEcCtD
Tolbutamide—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	2.08e-05	0.000516	CcSEcCtD
Tolbutamide—Urticaria—Glyburide—type 2 diabetes mellitus	2.05e-05	0.000507	CcSEcCtD
Tolbutamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	2.04e-05	0.000505	CcSEcCtD
Tolbutamide—Headache—Pioglitazone—type 2 diabetes mellitus	2.01e-05	0.000498	CcSEcCtD
Tolbutamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	2.01e-05	0.000496	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	2e-05	0.000495	CcSEcCtD
Tolbutamide—Probenecid—ABCC2—type 2 diabetes mellitus	1.99e-05	0.0185	CrCbGaD
Tolbutamide—Nausea—Glipizide—type 2 diabetes mellitus	1.99e-05	0.000493	CcSEcCtD
Tolbutamide—Rash—Glimepiride—type 2 diabetes mellitus	1.97e-05	0.000488	CcSEcCtD
Tolbutamide—Rash—Sitagliptin—type 2 diabetes mellitus	1.97e-05	0.000487	CcSEcCtD
Tolbutamide—Headache—Glimepiride—type 2 diabetes mellitus	1.96e-05	0.000485	CcSEcCtD
Tolbutamide—Headache—Sitagliptin—type 2 diabetes mellitus	1.95e-05	0.000483	CcSEcCtD
Tolbutamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.9e-05	0.00047	CcSEcCtD
Tolbutamide—Leukopenia—Losartan—type 2 diabetes mellitus	1.89e-05	0.000467	CcSEcCtD
Tolbutamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.87e-05	0.000464	CcSEcCtD
Tolbutamide—Nausea—Glimepiride—type 2 diabetes mellitus	1.86e-05	0.00046	CcSEcCtD
Tolbutamide—Nausea—Sitagliptin—type 2 diabetes mellitus	1.85e-05	0.000458	CcSEcCtD
Tolbutamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.85e-05	0.000458	CcSEcCtD
Tolbutamide—Urticaria—Gliclazide—type 2 diabetes mellitus	1.84e-05	0.000455	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.84e-05	0.000455	CcSEcCtD
Tolbutamide—Pruritus—Glyburide—type 2 diabetes mellitus	1.83e-05	0.000452	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.82e-05	0.000449	CcSEcCtD
Tolbutamide—Erythema—Ramipril—type 2 diabetes mellitus	1.81e-05	0.000448	CcSEcCtD
Tolbutamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.79e-05	0.000443	CcSEcCtD
Tolbutamide—Rash—Bromocriptine—type 2 diabetes mellitus	1.78e-05	0.00044	CcSEcCtD
Tolbutamide—Headache—Bromocriptine—type 2 diabetes mellitus	1.77e-05	0.000438	CcSEcCtD
Tolbutamide—Dyspepsia—Metformin—type 2 diabetes mellitus	1.71e-05	0.000422	CcSEcCtD
Tolbutamide—Urticaria—Valsartan—type 2 diabetes mellitus	1.69e-05	0.000418	CcSEcCtD
Tolbutamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.69e-05	0.000417	CcSEcCtD
Tolbutamide—Nausea—Bromocriptine—type 2 diabetes mellitus	1.68e-05	0.000415	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.67e-05	0.000414	CcSEcCtD
Tolbutamide—Urticaria—Orlistat—type 2 diabetes mellitus	1.67e-05	0.000413	CcSEcCtD
Tolbutamide—Pruritus—Gliclazide—type 2 diabetes mellitus	1.64e-05	0.000406	CcSEcCtD
Tolbutamide—Rash—Glyburide—type 2 diabetes mellitus	1.63e-05	0.000403	CcSEcCtD
Tolbutamide—Leukopenia—Ramipril—type 2 diabetes mellitus	1.62e-05	0.000401	CcSEcCtD
Tolbutamide—Headache—Glyburide—type 2 diabetes mellitus	1.62e-05	0.0004	CcSEcCtD
Tolbutamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.61e-05	0.000398	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.58e-05	0.000391	CcSEcCtD
Tolbutamide—Urticaria—Metformin—type 2 diabetes mellitus	1.54e-05	0.000381	CcSEcCtD
Tolbutamide—Nausea—Glyburide—type 2 diabetes mellitus	1.53e-05	0.000379	CcSEcCtD
Tolbutamide—Dyspepsia—Losartan—type 2 diabetes mellitus	1.52e-05	0.000375	CcSEcCtD
Tolbutamide—Pruritus—Valsartan—type 2 diabetes mellitus	1.51e-05	0.000373	CcSEcCtD
Tolbutamide—Pruritus—Orlistat—type 2 diabetes mellitus	1.49e-05	0.000368	CcSEcCtD
Tolbutamide—Glipizide—CYP3A4—type 2 diabetes mellitus	1.48e-05	0.0137	CrCbGaD
Tolbutamide—Rash—Gliclazide—type 2 diabetes mellitus	1.46e-05	0.000361	CcSEcCtD
Tolbutamide—Urticaria—Irbesartan—type 2 diabetes mellitus	1.45e-05	0.00036	CcSEcCtD
Tolbutamide—Headache—Gliclazide—type 2 diabetes mellitus	1.45e-05	0.000359	CcSEcCtD
Tolbutamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.45e-05	0.000358	CcSEcCtD
Tolbutamide—Nausea—Gliclazide—type 2 diabetes mellitus	1.38e-05	0.000341	CcSEcCtD
Tolbutamide—Pruritus—Metformin—type 2 diabetes mellitus	1.37e-05	0.000339	CcSEcCtD
Tolbutamide—Urticaria—Losartan—type 2 diabetes mellitus	1.37e-05	0.000338	CcSEcCtD
Tolbutamide—Rash—Valsartan—type 2 diabetes mellitus	1.34e-05	0.000332	CcSEcCtD
Tolbutamide—Headache—Valsartan—type 2 diabetes mellitus	1.33e-05	0.00033	CcSEcCtD
Tolbutamide—Rash—Orlistat—type 2 diabetes mellitus	1.33e-05	0.000328	CcSEcCtD
Tolbutamide—Headache—Orlistat—type 2 diabetes mellitus	1.32e-05	0.000326	CcSEcCtD
Tolbutamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.3e-05	0.000322	CcSEcCtD
Tolbutamide—Pruritus—Irbesartan—type 2 diabetes mellitus	1.29e-05	0.00032	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.27e-05	0.000315	CcSEcCtD
Tolbutamide—Nausea—Valsartan—type 2 diabetes mellitus	1.26e-05	0.000313	CcSEcCtD
Tolbutamide—Nausea—Orlistat—type 2 diabetes mellitus	1.25e-05	0.000309	CcSEcCtD
Tolbutamide—Rash—Metformin—type 2 diabetes mellitus	1.22e-05	0.000302	CcSEcCtD
Tolbutamide—Pruritus—Losartan—type 2 diabetes mellitus	1.22e-05	0.000301	CcSEcCtD
Tolbutamide—Headache—Metformin—type 2 diabetes mellitus	1.21e-05	0.0003	CcSEcCtD
Tolbutamide—Gliclazide—ALB—type 2 diabetes mellitus	1.2e-05	0.0111	CrCbGaD
Tolbutamide—Urticaria—Ramipril—type 2 diabetes mellitus	1.17e-05	0.00029	CcSEcCtD
Tolbutamide—Rash—Irbesartan—type 2 diabetes mellitus	1.15e-05	0.000285	CcSEcCtD
Tolbutamide—Nausea—Metformin—type 2 diabetes mellitus	1.15e-05	0.000285	CcSEcCtD
Tolbutamide—Headache—Irbesartan—type 2 diabetes mellitus	1.15e-05	0.000284	CcSEcCtD
Tolbutamide—Nausea—Irbesartan—type 2 diabetes mellitus	1.09e-05	0.000269	CcSEcCtD
Tolbutamide—Rash—Losartan—type 2 diabetes mellitus	1.09e-05	0.000269	CcSEcCtD
Tolbutamide—Headache—Losartan—type 2 diabetes mellitus	1.08e-05	0.000267	CcSEcCtD
Tolbutamide—Pruritus—Ramipril—type 2 diabetes mellitus	1.04e-05	0.000258	CcSEcCtD
Tolbutamide—Nausea—Losartan—type 2 diabetes mellitus	1.02e-05	0.000253	CcSEcCtD
Tolbutamide—Rash—Ramipril—type 2 diabetes mellitus	9.31e-06	0.00023	CcSEcCtD
Tolbutamide—Headache—Ramipril—type 2 diabetes mellitus	9.25e-06	0.000229	CcSEcCtD
Tolbutamide—Probenecid—CYP3A4—type 2 diabetes mellitus	8.82e-06	0.00817	CrCbGaD
Tolbutamide—Nausea—Ramipril—type 2 diabetes mellitus	8.77e-06	0.000217	CcSEcCtD
Tolbutamide—Probenecid—ALB—type 2 diabetes mellitus	7.69e-06	0.00713	CrCbGaD
Tolbutamide—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	1.34e-06	8.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	1.34e-06	8.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	1.34e-06	8.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MTHFR—type 2 diabetes mellitus	1.34e-06	8.61e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—INS—type 2 diabetes mellitus	1.32e-06	8.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HK1—type 2 diabetes mellitus	1.32e-06	8.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.32e-06	8.49e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—APOB—type 2 diabetes mellitus	1.32e-06	8.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.31e-06	8.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.31e-06	8.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PPARA—type 2 diabetes mellitus	1.31e-06	8.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.3e-06	8.35e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.28e-06	8.25e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GCKR—type 2 diabetes mellitus	1.28e-06	8.21e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—KCNJ11—type 2 diabetes mellitus	1.28e-06	8.21e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HSD3B2—type 2 diabetes mellitus	1.28e-06	8.21e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—LPA—type 2 diabetes mellitus	1.28e-06	8.21e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AGT—type 2 diabetes mellitus	1.27e-06	8.18e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.26e-06	8.14e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.26e-06	8.14e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	1.26e-06	8.1e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—LPL—type 2 diabetes mellitus	1.26e-06	8.1e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ALB—type 2 diabetes mellitus	1.25e-06	8.06e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CALM1—type 2 diabetes mellitus	1.25e-06	8.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—APOE—type 2 diabetes mellitus	1.24e-06	8.02e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.24e-06	7.99e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.24e-06	7.99e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.24e-06	7.98e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.23e-06	7.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—APOA1—type 2 diabetes mellitus	1.23e-06	7.92e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.23e-06	7.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.23e-06	7.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	1.22e-06	7.87e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.22e-06	7.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.22e-06	7.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.22e-06	7.86e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ALB—type 2 diabetes mellitus	1.21e-06	7.81e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.21e-06	7.78e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.2e-06	7.71e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NOS3—type 2 diabetes mellitus	1.2e-06	7.71e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CD36—type 2 diabetes mellitus	1.2e-06	7.7e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.19e-06	7.65e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.18e-06	7.62e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.18e-06	7.6e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	1.18e-06	7.59e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.18e-06	7.58e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.16e-06	7.49e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PIK3R1—type 2 diabetes mellitus	1.16e-06	7.47e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NOS3—type 2 diabetes mellitus	1.16e-06	7.47e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.15e-06	7.41e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.15e-06	7.39e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	1.14e-06	7.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	1.14e-06	7.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	1.14e-06	7.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	1.14e-06	7.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	1.14e-06	7.32e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.13e-06	7.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.13e-06	7.27e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.11e-06	7.15e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.1e-06	7.1e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTGS2—type 2 diabetes mellitus	1.09e-06	7.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.09e-06	7.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.09e-06	7.03e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PPARG—type 2 diabetes mellitus	1.08e-06	6.98e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AGT—type 2 diabetes mellitus	1.08e-06	6.93e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.07e-06	6.92e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.07e-06	6.91e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—INS—type 2 diabetes mellitus	1.06e-06	6.85e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTGS2—type 2 diabetes mellitus	1.06e-06	6.84e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	1.06e-06	6.83e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.06e-06	6.82e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.06e-06	6.81e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—APOE—type 2 diabetes mellitus	1.05e-06	6.79e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.04e-06	6.71e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	1.04e-06	6.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	1.04e-06	6.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.04e-06	6.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.04e-06	6.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.04e-06	6.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.04e-06	6.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.04e-06	6.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.03e-06	6.61e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	1.02e-06	6.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	1.01e-06	6.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.01e-06	6.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	1.01e-06	6.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	1.01e-06	6.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	1.01e-06	6.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	1.01e-06	6.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.98e-07	6.42e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	9.95e-07	6.41e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	9.89e-07	6.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	9.77e-07	6.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ALB—type 2 diabetes mellitus	9.75e-07	6.28e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.67e-07	6.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	9.47e-07	6.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.47e-07	6.1e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.36e-07	6.03e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PIK3R1—type 2 diabetes mellitus	9.33e-07	6e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NOS3—type 2 diabetes mellitus	9.33e-07	6e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	9.28e-07	5.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	9.28e-07	5.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	9.25e-07	5.96e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PPARG—type 2 diabetes mellitus	9.19e-07	5.91e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.11e-07	5.87e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	9.1e-07	5.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	9.09e-07	5.85e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	9.09e-07	5.85e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	9.09e-07	5.85e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	9.05e-07	5.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	9.04e-07	5.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	9.04e-07	5.82e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	9.04e-07	5.82e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—INS—type 2 diabetes mellitus	9.01e-07	5.8e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	8.99e-07	5.79e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	8.92e-07	5.74e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	8.84e-07	5.69e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	8.83e-07	5.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	8.72e-07	5.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	8.72e-07	5.61e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	8.65e-07	5.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	8.64e-07	5.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTGS2—type 2 diabetes mellitus	8.53e-07	5.49e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	8.46e-07	5.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	8.46e-07	5.45e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	8.31e-07	5.35e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	8.3e-07	5.34e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	8.26e-07	5.32e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.25e-07	5.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	8.25e-07	5.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	8.25e-07	5.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	8.25e-07	5.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	8.22e-07	5.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	8.22e-07	5.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	8.19e-07	5.28e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.13e-07	5.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	8.11e-07	5.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	8.11e-07	5.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	8.11e-07	5.22e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	8.05e-07	5.18e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	8.01e-07	5.16e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.97e-07	5.13e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	7.96e-07	5.13e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	7.95e-07	5.12e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.9e-07	5.09e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.9e-07	5.09e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	7.89e-07	5.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	7.88e-07	5.07e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	7.88e-07	5.07e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.78e-07	5.01e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	7.72e-07	4.97e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	7.42e-07	4.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.42e-07	4.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	7.4e-07	4.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	7.4e-07	4.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	7.4e-07	4.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	7.33e-07	4.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	7.33e-07	4.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	7.26e-07	4.67e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.23e-07	4.65e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	7.19e-07	4.63e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	7.15e-07	4.61e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.12e-07	4.58e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.09e-07	4.57e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	7.04e-07	4.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	7.03e-07	4.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	7.03e-07	4.53e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.79e-07	4.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	6.79e-07	4.37e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	6.76e-07	4.35e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	6.76e-07	4.35e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	6.69e-07	4.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	6.69e-07	4.31e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	6.67e-07	4.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	6.52e-07	4.2e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.49e-07	4.18e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	6.47e-07	4.17e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	6.41e-07	4.13e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	6.41e-07	4.13e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	6.3e-07	4.05e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	6.18e-07	3.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	6.06e-07	3.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.06e-07	3.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	6.05e-07	3.9e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	6.03e-07	3.88e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	6.03e-07	3.88e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	5.95e-07	3.83e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	5.87e-07	3.78e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	5.8e-07	3.73e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	5.78e-07	3.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	5.62e-07	3.62e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	5.57e-07	3.58e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	5.53e-07	3.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.53e-07	3.56e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	5.52e-07	3.55e-05	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—AKT1—type 2 diabetes mellitus	5.5e-07	3.54e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	5.5e-07	3.54e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	5.46e-07	3.52e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	5.43e-07	3.49e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	5.4e-07	3.48e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	5.38e-07	3.47e-05	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—AKT1—type 2 diabetes mellitus	5.34e-07	3.44e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	5.29e-07	3.4e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	5.27e-07	3.39e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	5.24e-07	3.38e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	5.2e-07	3.35e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	5.18e-07	3.34e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	5.18e-07	3.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	5.13e-07	3.3e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	5.12e-07	3.3e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	5.03e-07	3.24e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	4.97e-07	3.2e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.93e-07	3.17e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.91e-07	3.16e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.87e-07	3.14e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.78e-07	3.08e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.72e-07	3.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.72e-07	3.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	4.64e-07	2.99e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	4.63e-07	2.98e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	4.57e-07	2.94e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.53e-07	2.92e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	4.51e-07	2.91e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.44e-07	2.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	4.43e-07	2.85e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	4.3e-07	2.77e-05	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	4.29e-07	2.76e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.23e-07	2.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.22e-07	2.72e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	4.17e-07	2.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	4.06e-07	2.61e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	4.03e-07	2.59e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.95e-07	2.54e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.88e-07	2.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.88e-07	2.5e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.67e-07	2.37e-05	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.63e-07	2.34e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.62e-07	2.33e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.6e-07	2.32e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	3.55e-07	2.29e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	3.47e-07	2.23e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	3.47e-07	2.23e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.3e-07	2.13e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.17e-07	2.04e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.16e-07	2.03e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.16e-07	2.03e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.89e-07	1.86e-05	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.78e-07	1.15e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.59e-07	1.03e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.45e-07	9.35e-06	CbGpPWpGaD
